Search research articles
Contact Us
Filters
Showing results (261-270 of 269) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 269 results.
Nature
|
October 13, 2022
Author Correction: Heterodimensional superlattice with in-plane anomalous Hall effect
Jiadong Zhou, Wenjie Zhang, Yung-Chang Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy
Wen-Chi Chou, Pei-Hung Chang, Ping-Tsung Chen, et al.
Anticancer Research
|
March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations
Ming-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Nature
|
August 31, 2022
Heterodimensional superlattice with in-plane anomalous Hall effect
Jiadong Zhou, Wenjie Zhang, Yung-Chang Lin, et al.
Science Advances
|
January 31, 2020
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Kuan-Wei Huang, Fu-Fei Hsu, Jiantai Timothy Qiu, et al.
Nature Materials
|
June 23, 2022
Composition and phase engineering of metal chalcogenides and phosphorous chalcogenides
Jiadong Zhou, Chao Zhu, Yao Zhou, et al.
Nature Communications
|
February 21, 2026
Crafting moiré superlattices in twisted complex oxide-transition metal dichalcogenide heterostructures
Rahul, Puneet Kaur, Jia-Yuan Sun, et al.
International Journal of Cancer
|
November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2024
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
Herui Yao, Min Yan, Zhongsheng Tong, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 269) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 269 results.
Nature
|
October 13, 2022
Author Correction: Heterodimensional superlattice with in-plane anomalous Hall effect
Jiadong Zhou, Wenjie Zhang, Yung-Chang Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy
Wen-Chi Chou, Pei-Hung Chang, Ping-Tsung Chen, et al.
Anticancer Research
|
March 9, 2012
Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations
Ming-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, et al.
Nature
|
August 31, 2022
Heterodimensional superlattice with in-plane anomalous Hall effect
Jiadong Zhou, Wenjie Zhang, Yung-Chang Lin, et al.
Science Advances
|
January 31, 2020
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Kuan-Wei Huang, Fu-Fei Hsu, Jiantai Timothy Qiu, et al.
Nature Materials
|
June 23, 2022
Composition and phase engineering of metal chalcogenides and phosphorous chalcogenides
Jiadong Zhou, Chao Zhu, Yao Zhou, et al.
Nature Communications
|
February 21, 2026
Crafting moiré superlattices in twisted complex oxide-transition metal dichalcogenide heterostructures
Rahul, Puneet Kaur, Jia-Yuan Sun, et al.
International Journal of Cancer
|
November 8, 2022
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Hung-Kai Chen, Po-Jung Su, Yan-Lin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2024
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
Herui Yao, Min Yan, Zhongsheng Tong, et al.
Page
of 27